Can mesothelioma cause neuropathy and anemia in older adults with a history of asbestos exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Mesothelioma Cause Neuropathy and Anemia?

Yes, mesothelioma can cause both neuropathy and anemia, though these are uncommon manifestations that typically occur in advanced disease stages.

Neuropathic Pain in Mesothelioma

Neuropathic pain is a recognized complication of malignant pleural mesothelioma, occurring through direct tumor invasion of neural structures:

  • Approximately 54% of mesothelioma patients develop clinically diagnosed neuropathic pain, though only 40% of these screen positive on standardized neuropathic pain assessment tools like the LANSS 1
  • The neuropathy results from direct tumor extension into chest wall structures, intercostal nerves, and brachial plexus, particularly in locally advanced disease 1
  • Patients with neuropathic components report higher pain interference scores and require more complex analgesic regimens beyond standard pain management 1
  • The presence of neuropathic pain does not predict response to palliative radiotherapy 1

Clinical Recognition

Look specifically for:

  • Burning, shooting, or electric shock-like pain quality 1
  • Allodynia or hyperalgesia in the chest wall distribution 1
  • Pain that persists despite adequate opioid dosing 1

Anemia in Mesothelioma

Anemia can occur in mesothelioma through two distinct mechanisms:

1. Bone Marrow Metastasis (Rare but Severe)

  • Bone marrow involvement represents terminal-stage disease with rapid clinical deterioration 2
  • Presents with pancytopenia: anemia, leukoerythroblastosis, and thrombocytopenia 2
  • Median survival after bone marrow metastasis detection is approximately 15 days 2
  • Bone marrow biopsy is required for definitive diagnosis when peripheral blood shows leukoerythroblastic picture 2

2. Anemia of Chronic Disease (More Common)

  • Occurs as part of the systemic inflammatory response to advanced malignancy 3
  • Typically mild to moderate in severity
  • Associated with overall disease burden and poor performance status 3

Clinical Implications for Older Adults with Asbestos Exposure

When evaluating older adults with asbestos exposure history who present with neuropathy or anemia:

  • Obtain chest imaging immediately if not already performed, as mesothelioma typically presents with unilateral pleural thickening or effusion 3
  • Document the temporal relationship: neuropathy developing concurrently with respiratory symptoms suggests local tumor invasion 1
  • Perform complete blood count with differential: leukoerythroblastosis indicates bone marrow involvement and warrants urgent bone marrow biopsy 2
  • Assess for other red flags: chest pain, dyspnea, weight loss, and pleural effusion are the cardinal presenting features 3

Important Caveats

  • Neuropathy from mesothelioma indicates locally advanced disease requiring multidisciplinary evaluation by experienced thoracic oncology teams 3
  • Bone marrow metastasis represents end-stage disease where palliative care should be the primary focus 2
  • Do not attribute neuropathy or anemia to mesothelioma without tissue diagnosis, as these symptoms have multiple potential etiologies in older adults 3
  • The latency period between asbestos exposure and mesothelioma development is typically 30-40 years 3, so recent exposure makes mesothelioma less likely

References

Research

Malignant Pleural Mesothelioma with Bone Marrow Metastases.

Internal medicine (Tokyo, Japan), 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.